4893 items matching your search terms.

Measuring trade-offs in nephrology: A systematic review of discrete choice experiments and conjoint analysis studies

Clark, M. D. Szczepura, A. Gumber, A. Howard, K. Moro, D. Morton, R. L.
NEPHROLOGY, DIALYSIS, TRANSPLANTATION, 2018     DOI:10.1093/ndt/gfw436

Age-dependent changes to sphingolipid balance in the human hippocampus are gender-specific and may sensitize to neurodegeneration

Couttas, T. A. Kain, N. Tran, C. Chatterton, Z. Kwok, J. B. Don, A. S.
JOURNAL OF ALZHEIMER'S DISEASE, 2018     DOI:10.3233/JAD-171054

Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion

Critselis, E. Vlahou, A. Stel, V. S. Morton, R. L.
NEPHROLOGY, DIALYSIS, TRANSPLANTATION, 2018     DOI:10.1093/ndt/gfx068

Validation of questionnaire and diary measures of time outdoors against an objective measure of personal ultraviolet radiation exposure

Cust, A. E. Fenton, G. L. Smit, A. K. Espinoza, D. Dobbinson, S. Brodie, A. Dang, H. T. C. Kimlin, M. G.
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2018     DOI:10.1111/php.12893

Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016)

Daniels, B. Girosi, F. Tervonen, H. Kiely, B. E. Lord, S. J. Houssami, N. Pearson, S. A.
PLOS ONE, 2018     DOI:10.1371/journal.pone.0198152

Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: A national population-based observational study (2006-2014)

Daniels, B. Kiely, B. E. Houssami, N. Lord, S. J. Dobbins, T. Lu, C. Y. Ward, R. L. Pearson, S. A.
BRITISH JOURNAL OF CANCER, 2018     DOI:10.1038/bjc.2017.405

Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: Real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)

Daniels, B. Kiely, B. E. Lord, S. J. Houssami, N. Lu, C. Y. Ward, R. L. Pearson, S. A.
BREAST CANCER RESEARCH AND TREATMENT, 2018     DOI:10.1007/s10549-018-4804-0

Trastuzumab for metastatic breast cancer: Real world outcomes from an Australian whole-of-population cohort (2001-2016)

Daniels, B. Kiely, B. E. Lord, S. J. Houssami, N. Lu, C. Y. Ward, R. L. Pearson, S. A.
BREAST, 2018     DOI:10.1016/j.breast.2017.11.007

Effect of placental transfusion on iron stores in moderately preterm neonates of 30-33 weeks gestation

Das, B. Sundaram, V. Kumar, P. Mordi, W. T. Dhaliwal, L. K. Das, R.
INDIAN JOURNAL OF PEDIATRICS, 2018     DOI:10.1007/s12098-017-2490-2

Placental transfusion in preterm neonates of 30-33 weeks' gestation: A randomized controlled trial

Das, B. Sundaram, V. Tarnow-Mordi, W. Ghadge, A. Dhaliwal, L. K. Kumar, P.
JOURNAL OF PERINATOLOGY, 2018     DOI:10.1038/s41372-018-0064-4

Renal trials in diabetes need a platform: time for a global approach?

de Zeeuw, D. Heerspink, H. J. L. Jardine, M. Perkovic, V.
LANCET DIABETES ENDOCRINOL, 2018     DOI:10.1016/S2213-8587(17)30263-2

Performance of four published risk models to predict sentinel lymph-node involvement in Australian women with early breast cancer

Elmadahm, A. Lord, S. J. Hudson, H. M. Lee, C. K. Buizen, L. Farshid, G. Gebski, V. J. Gill, P. G.
BREAST, 2018     DOI:10.1016/j.breast.2018.05.011

Profiles of brain metastases: prioritization of therapeutic targets

Ferguson, S. D. Zheng, S. Xiu, J. Zhou, S. Khasraw, M. Brastianos, P. K. Kesari, S. Hu, J. Rudnick, J. Salacz, M. E. Piccioni, D. Huang, S. Davies, M. A. Glitza, I. C. Heymach, J. V. Zhang, J. Ibrahim, N. K. DeGroot, J. F. McCarty, J. O'Brien, B. J. Sawaya, R. Verhaak, R. G. W. Reddy, S. K. Priebe, W. Gatalica, Z. Spetzler, D. Heimberger, A. B.
INTERNATIONAL JOURNAL OF CANCER, 2018     DOI:10.1002/ijc.31624

Delayed vs early umbilical cord clamping for preterm infants: A systematic review and meta-analysis

Fogarty, M. Osborn, D. A. Askie, L. Seidler, A. L. Hunter, K. Lui, K. Simes, J. Tarnow-Mordi, W.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018     DOI:10.1016/j.ajog.2017.10.231

Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial

Friedlander, M. Gebski, V. Gibbs, E. Davies, L. Bloomfield, R. Hilpert, F. Wenzel, L. B. Eek, D. Rodrigues, M. Clamp, A. Penson, R. T. Provencher, D. Korach, J. Huzarski, T. Vidal, L. Salutari, V. Scott, C. Nicoletto, M. O. Tamura, K. Espinoza, D. Joly, F. Pujade-Lauraine, E.
LANCET ONCOLOGY, 2018     DOI:10.1016/S1470-2045(18)30343-7